These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
488 related items for PubMed ID: 32768352
1. The Utility of the Fifth Edition of the BI-RADS Ultrasound Lexicon in Category 4 Breast Lesions: A Prospective Multicenter Study in China. Gu Y, Tian JW, Ran HT, Ren WD, Chang C, Yuan JJ, Kang CS, Deng YB, Wang H, Luo BM, Guo SL, Zhou Q, Xue ES, Zhan WW, Zhou Q, Li J, Zhou P, Zhang CQ, Chen M, Gu Y, Xu JF, Chen W, Zhang YH, Wang HQ, Li JC, Wang HY, Jiang YX. Acad Radiol; 2022 Jan; 29 Suppl 1():S26-S34. PubMed ID: 32768352 [Abstract] [Full Text] [Related]
2. Assessment of Diagnostic Accuracy and Efficiency of Categories 4 and 5 of the Second Edition of the BI-RADS Ultrasound Lexicon in Diagnosing Breast Lesions. Zou X, Wang J, Lan X, Lin Q, Han F, Liu L, Li A. Ultrasound Med Biol; 2016 Sep; 42(9):2065-71. PubMed ID: 27262521 [Abstract] [Full Text] [Related]
3. Nonpalpable BI-RADS 4 breast lesions: sonographic findings and pathology correlation. Elverici E, Barça AN, Aktaş H, Özsoy A, Zengin B, Çavuşoğlu M, Araz L. Diagn Interv Radiol; 2015 Sep; 21(3):189-94. PubMed ID: 25835079 [Abstract] [Full Text] [Related]
4. BI-RADS lexicon for US and mammography: interobserver variability and positive predictive value. Lazarus E, Mainiero MB, Schepps B, Koelliker SL, Livingston LS. Radiology; 2006 May; 239(2):385-91. PubMed ID: 16569780 [Abstract] [Full Text] [Related]
5. Prediction for Breast Cancer in BI-RADS Category 4 Lesion Categorized by Age and Breast Composition of Women in Songklanagarind Hospital. Noonpradej S, Wangkulangkul P, Woodtichartpreecha P, Laohawiriyakamol S. Asian Pac J Cancer Prev; 2021 Feb 01; 22(2):531-536. PubMed ID: 33639670 [Abstract] [Full Text] [Related]
6. Ultrasound positive predictive values by BI-RADS categories 3-5 for solid masses: An independent reader study. Stavros AT, Freitas AG, deMello GGN, Barke L, McDonald D, Kaske T, Wolverton D, Honick A, Stanzani D, Padovan AH, Moura APC, de Campos MCV. Eur Radiol; 2017 Oct 01; 27(10):4307-4315. PubMed ID: 28396996 [Abstract] [Full Text] [Related]
11. Predictive value of contrast-enhanced ultrasonography and ultrasound elastography for management of BI-RADS category 4 nonpalpable breast masses. Niu Q, Zhao L, Wang R, Du L, Shi Q, Jia C, Li G, Jin L, Li F. Eur J Radiol; 2024 Apr 01; 173():111391. PubMed ID: 38422608 [Abstract] [Full Text] [Related]
14. Downgrading and Upgrading Gray-Scale Ultrasound BI-RADS Categories of Benign and Malignant Masses With Optoacoustics: A Pilot Study. Neuschler EI, Lavin PT, Tucker FL, Barke LD, Bertrand ML, Böhm-Vélez M, Destounis S, Dogan BE, Grobmyer SR, Katzen J, Kist KA, Makariou EV, Parris TM, Young CA, Butler R. AJR Am J Roentgenol; 2018 Sep 01; 211(3):689-700. PubMed ID: 29975115 [Abstract] [Full Text] [Related]
20. The value of elastography strain rate ratio in benign and malignant BI-RADS-US 3-4 breast masses. Li X, Sun W, Zhang H. Biomol Biomed; 2024 May 02; 24(3):625-632. PubMed ID: 38149832 [Abstract] [Full Text] [Related] Page: [Next] [New Search]